2023 BIO International Convention is the world's largest biotechnology conference for innovation, truth, science and breakthrough biotech performs.

Go to booth and meet us directly, there prepares little surprises!

2023 BIO International Convention is the world's largest biotechnology conference for innovation, truth, science and breakthrough biotech performs.

bioSeedin, holding by ACROBiosystems, is an international license service provider, aiming to connect your promising therapeutic with our global partners and resources. More than 50 high-quality assets are owned by us, including small molecule, protein drug, ADC/PDC and GCT, covering neurological disease, metabolic disease, oncology/cancer, respiratory disease, cardiovascular disease, immunological disease, infectious and parasitic diseases and etc.

Here listed partial assets we will bring to BIO Boston:

Projects

Indications

Phase

Territory

Modified vilazodone

MDD

BE study finished

Global

Claudin18.2 CAR-T

Advanced gastric cancer,Advanced pancreatic cancer,

IND Approval

Global

EpCAM18.2 CAR-T

Advanced Gastrointestinal Cancer

IIT

Global

FXR agonist

Hepatitis、NASH

Finish P I in AU

Global

URAT1/XO inhibitor

Gout, Hyperuricemia

Phase I ongoing

Global

B7-H3×CD3 bsAb

Advanced Solid Tumor

IND Approval

Global

GLP-1/GIP/FGF21 Fc fusion protein

T2DM,NASH

preclinical

Global except China

Class I PI3K/mTOR inhibitor

Solid tumor, IPF

Finished P I in USA

(Orphan drug qualification)

Global

If you are willing to meet us there,

or if you fail to schedule attending this conference but hoping to do assets-licensing by our support,

please click here or reply to this email directly.

Looking forward to meeting you!

Our team

To receive the latest asset list from bioSeedin,

visit our website & follow us on our social media!

Email  LinkedIn  Web

"Connecting your promising therapeutic with our global partners and resources"